Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3881646 | 0.85 | TSHR (0.39) | CA2CA12CA1CA4CA7 | |
| SCHEMBL29468633 | 0.84 | HPGD (0.36) | CA2CA12CA1CA4CA7 | |
| SCHEMBL777572 | 0.84 | HPGD (0.36) | CA2CA12CA1CA4CA7 | |
| SCHEMBL21319400 | 0.84 | CA1 (0.37) | CA2CA12CA1CA4CA7 | |
| SCHEMBL31306423 | 0.84 | CYP3A4 (0.46) | CA2CA12CA1CA4CA7 | |
| SCHEMBL24596898 | 0.84 | ALDH1A1 (0.41) | CA2CA12CA1CA4CA7 | |
| SCHEMBL10722239 | 0.84 | CA1 (0.50) | CA2CA12CA1CA4CA7 | |
| SCHEMBL4454668 | 0.82 | L3MBTL1 (0.37) | CA2CA12CA1CA4CA7 | |
| SCHEMBL10721636 | 0.80 | KDM4E (0.42) | POLBLMNAMEN1KMT2ATDP1 | |
| SCHEMBL16270675 | 0.80 | CA12 (0.32) | CA2CA12CA1CA4CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109293805-A | Olefin polymerization solid catalytic component, component preparation method and catalyst system thereof | 中国石油天然气股份有限公司 | 2019-02-01 | — | — | CN | claimed |
| US-20090221530-A1 | Relaxase Modulators and Methods of Using Same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-09-03 | — | — | US | claimed |
| US-5698022-A | METAL OXIDE CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1997-12-16 | — | — | US | claimed |
| CN-110416621-A | A method of inorganic solid electrolyte is handled using phosphorus-containing matter | INST CHEMISTRY CAS | 2019-11-05 | — | — | CN | disclosed |
| CN-109293805-A | Olefin polymerization solid catalytic component, component preparation method and catalyst system thereof | 中国石油天然气股份有限公司 | 2019-02-01 | — | — | CN | disclosed |
| US-8642003-B2 | Phosphine-oxide catalyzed process of production of hydrogen from silylated derivatives as hydrogen carrier | UNIVERSITE D'AIX-MARSEILLE (FR) | 2014-02-04 | — | — | US | disclosed |
| US-8642003-B2 | Phosphine-oxide catalyzed process of production of hydrogen from silylated derivatives as hydrogen carrier | UNIVERSITE D'AIX-MARSEILLE (FR) | 2014-02-04 | — | — | US | disclosed |
| US-20130189183-A1 | Phosphine-Oxide Catalyzed Process of Production of Hydrogen from Silylated Derivatives as Hydrogen Carrier | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2013-07-25 | — | — | US | disclosed |
| US-20130189183-A1 | Phosphine-Oxide Catalyzed Process of Production of Hydrogen from Silylated Derivatives as Hydrogen Carrier | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2013-07-25 | — | — | US | disclosed |
| WO-2011098614-A1 | PHOSPHINE-OXIDE CATALYZED PROCESS OF PRODUCTION OF HYDROGEN FROM SILYLATED DERIVATIVES AS HYDROGEN CARRIER | UNIVERSITE DE LA MEDITERRANEE AIX-MARSEILLE II (FR) | 2011-08-18 | — | — | WO | disclosed |
| CN-100577624-C | Process for the production of acetic acid | BP CHEM INT LTD | 2010-01-06 | — | — | CN | disclosed |
| US-20090221530-A1 | Relaxase Modulators and Methods of Using Same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-09-03 | — | — | US | disclosed |
| US-7256308-B2 | Carbonylating methanol with an iridium carbonylation catalyst, methyl iodide, methyl acetate, water, acetic acid, a promoter of ruthenium, rhenium or osmium, and a bis-phosphonate compound | BP CHEMICALS LIMITED (GB) | 2007-08-14 | — | — | US | disclosed |
| WO-2007056543-A2 | RELAXASE MODULATORS AND METHODS OF USING SAME | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2007-05-18 | — | — | WO | disclosed |
| CN-1659127-A | Process for the preparation of acetic acid | BP CHEM INT LTD (GB) | 2005-08-24 | — | — | CN | disclosed |
| US-20050131251-A1 | Process for the production of acetic acid | BP CHEMICALS LIMITED (GB) | 2005-06-16 | — | — | US | disclosed |
| EP-1509488-A1 | PROCESS FOR THE PRODUCTION OF ACETIC ACID | BP Chemicals Limited (GB) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003104179-A1 | PROCESS FOR THE PRODUCTION OF ACETIC ACID | BP CHEMICALS LIMITED (GB) | 2003-12-18 | — | — | WO | disclosed |
| US-5698022-A | METAL OXIDE CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1997-12-16 | — | — | US | disclosed |
| US-5698022-A | METAL OXIDE CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1997-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131251-A1 | Process for the production of acetic acid | ME1, INO80C, INO80 | CA2 239/4885CA12 275/4885CA1 79/4885 |
| US-20090221530-A1 | Relaxase Modulators and Methods of Using Same | RXFP1, RXFP2, RXFP4 | CA2 1156/4885CA12 2087/4885CA1 2118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.